CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 174 enrolled
Drug / intervention
Varenicline +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03980561
NCT03980561Phase 2Completed
CompareCT.gov

Varenicline for the Treatment of DSM 5 Cannabis Use Disorder in Adults

Medical University of South Carolina·interventional·Posted Jun 10, 2019·Updated Jan 18, 2024

In Brief

A Phase 2 clinical trial evaluating Varenicline and Placebo for Cannabis Use Disorder. Completed, enrolled 174 participants across 2 sites.

Detailed Summary

Marijuana is the most commonly used illicit drug. There is high demand for effective interventions for cannabis use disorder, yet few specific treatments for have been developed. This study will evaluate the efficacy of varenicline for reducing marijuana use in people who use marijuana frequently.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCannabis Use Disorder
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2020202120222023202420252026
First PostedJun 10, 2019
Enrollment StartJan 31, 2020
Primary CompletionFeb 9, 2023
Study CompletionDec 1, 2023
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 7.1 years ago

Interventions

Vareniclinedrug

Active medication

Placebodrug

Inactive medication